MedPath

Safety and Effectiveness of Four Anti-HIV Drug Combinations in HIV-Infected Children and Teens

Phase 1
Completed
Conditions
HIV Infections
Registration Number
NCT00001091
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Brief Summary

The purpose of this study is to see if it is safe and effective to give HIV-infected children and teens 1 of 4 anti-HIV drug combinations.

Decreasing HIV levels in infected patients can slow down disease progression. Further study is needed to find out which drug combinations are most effective in doing this.

Detailed Description

For PRAM 2: Evidence suggests that as a consequence of antiviral therapy, decreases in plasma HIV-1 RNA are strongly associated with a delay in clinical progression. Therefore, the drug regimens proposed in this study are designed to result in a much larger sustained drop in plasma HIV-1 RNA and greater clinical benefit. Further intent of this study is to evaluate the virologic and therapeutic potential of novel combinations of antiretrovirals and to better define the pharmacokinetics and drug-drug interactions of therapies included in this regimen.

The Master PRAM schema is designed to allow new therapeutic arms to be studied as "rolling screens" through multiple generations of PRAMs. There is a common, "linking" regimen between any 2 sequential PRAM generations that will permit an indirect comparison of included therapies. (NOTE: Due to significant changes in study design between PRAM 1 and PRAM 2, there is no "linking" arm between them. The linkage will be reinstated from PRAM 2 and subsequent PRAM generations.) The therapeutic potential of the treatment arms is assessed by their ability to decrease HIV copy numbers as defined by plasma HIV-1 RNA copy number. Once accrual to a PRAM is complete, a new treatment comparison will open for accrual.

For PRAM 2: This study will compare the following 4 treatment arms:

Arm A - stavudine (d4T)/nevirapine/ritonavir Arm B - d4T/lamivudine (3TC)/nelfinavir Arm C - d4T/nevirapine/nelfinavir Arm D - d4T/3TC/nevirapine/nelfinavir. Prior to randomization to 1 of the PRAM 2 treatment arms, patients are stratified based on their CD4% (less than 25% and greater than or equal to 25%) and by age (less than 24 months and greater than or equal to 24 months). The first 35 subjects/treatment arm are evaluated with special immunologic studies including lymphoproliferative assays and extended panel immunophenotyping. There is an interim analysis after all patients have completed 12 weeks of treatment. Patients are treated for 48 weeks. \[AS PER AMENDMENT 6/11/99: The study has been extended for an additional 48 weeks (96 weeks total) to permit long-term follow-up of clinically stable, HIV-infected children.\]

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
200
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (55)

Harbor - UCLA Med Ctr / UCLA School of Medicine

πŸ‡ΊπŸ‡Έ

Los Angeles, California, United States

State Univ of New York at Stony Brook

πŸ‡ΊπŸ‡Έ

Stony Brook, New York, United States

Children's Hosp of Philadelphia

πŸ‡ΊπŸ‡Έ

Philadelphia, Pennsylvania, United States

Saint Christopher's Hosp for Children

πŸ‡ΊπŸ‡Έ

Philadelphia, Pennsylvania, United States

Children's Hospital & Medical Center / Seattle ACTU

πŸ‡ΊπŸ‡Έ

Seattle, Washington, United States

Yale Univ Med School

πŸ‡ΊπŸ‡Έ

New Haven, Connecticut, United States

Palm Beach County Health Dept

πŸ‡ΊπŸ‡Έ

Riviera Beach, Florida, United States

Children's Hosp of Washington DC

πŸ‡ΊπŸ‡Έ

Washington, District of Columbia, United States

Howard Univ Hosp

πŸ‡ΊπŸ‡Έ

Washington, District of Columbia, United States

Washington Hosp Ctr

πŸ‡ΊπŸ‡Έ

Washington, District of Columbia, United States

Med Univ of South Carolina

πŸ‡ΊπŸ‡Έ

Charleston, South Carolina, United States

North Broward Hosp District

πŸ‡ΊπŸ‡Έ

Fort Lauderdale, Florida, United States

San Juan City Hosp

πŸ‡΅πŸ‡·

San Juan, Puerto Rico

Ramon Ruiz Arnau Univ Hosp / Pediatrics

πŸ‡΅πŸ‡·

Bayamon, Puerto Rico

UCSF / Moffitt Hosp - Pediatric

πŸ‡ΊπŸ‡Έ

San Francisco, California, United States

Vanderbilt Univ Med Ctr

πŸ‡ΊπŸ‡Έ

Nashville, Tennessee, United States

UCSD Med Ctr / Pediatrics / Clinical Sciences

πŸ‡ΊπŸ‡Έ

La Jolla, California, United States

Univ of Alabama at Birmingham - Pediatric

πŸ‡ΊπŸ‡Έ

Birmingham, Alabama, United States

Long Beach Memorial (Pediatric)

πŸ‡ΊπŸ‡Έ

Long Beach, California, United States

Children's Hosp of Los Angeles/UCLA Med Ctr

πŸ‡ΊπŸ‡Έ

Los Angeles, California, United States

Los Angeles County - USC Med Ctr

πŸ‡ΊπŸ‡Έ

Los Angeles, California, United States

UCLA Med Ctr / Pediatric

πŸ‡ΊπŸ‡Έ

Los Angeles, California, United States

Connecticut Children's Med Ctr - Pediatric

πŸ‡ΊπŸ‡Έ

Hartford, Connecticut, United States

Children's Hosp of Oakland

πŸ‡ΊπŸ‡Έ

Oakland, California, United States

Univ of Florida Gainesville

πŸ‡ΊπŸ‡Έ

Gainesville, Florida, United States

Univ of Florida Health Science Ctr / Pediatrics

πŸ‡ΊπŸ‡Έ

Jacksonville, Florida, United States

Univ of Illinois College of Medicine / Pediatrics

πŸ‡ΊπŸ‡Έ

Chicago, Illinois, United States

Emory Univ Hosp / Pediatrics

πŸ‡ΊπŸ‡Έ

Atlanta, Georgia, United States

Med College of Georgia

πŸ‡ΊπŸ‡Έ

Augusta, Georgia, United States

Chicago Children's Memorial Hosp

πŸ‡ΊπŸ‡Έ

Chicago, Illinois, United States

Cook County Hosp

πŸ‡ΊπŸ‡Έ

Chicago, Illinois, United States

Johns Hopkins Hosp - Pediatric

πŸ‡ΊπŸ‡Έ

Baltimore, Maryland, United States

Univ of Maryland at Baltimore / Univ Med Ctr

πŸ‡ΊπŸ‡Έ

Baltimore, Maryland, United States

Univ of Chicago Children's Hosp

πŸ‡ΊπŸ‡Έ

Chicago, Illinois, United States

Tulane Univ / Charity Hosp of New Orleans

πŸ‡ΊπŸ‡Έ

New Orleans, Louisiana, United States

Saint Joseph's Hosp and Med Ctr/UMDNJ - New Jersey Med Schl

πŸ‡ΊπŸ‡Έ

Newark, New Jersey, United States

Baystate Med Ctr of Springfield

πŸ‡ΊπŸ‡Έ

Springfield, Massachusetts, United States

Univ of Mississippi Med Ctr

πŸ‡ΊπŸ‡Έ

Jackson, Mississippi, United States

Univ of Massachusetts Med School

πŸ‡ΊπŸ‡Έ

Worcester, Massachusetts, United States

Bronx Lebanon Hosp Ctr

πŸ‡ΊπŸ‡Έ

Bronx, New York, United States

Bronx Municipal Hosp Ctr/Jacobi Med Ctr

πŸ‡ΊπŸ‡Έ

Bronx, New York, United States

King's County Hosp Ctr / Pediatrics

πŸ‡ΊπŸ‡Έ

Brooklyn, New York, United States

Bronx Municipal Hosp Ctr / Bronx Lebanon Hosp Ctr

πŸ‡ΊπŸ‡Έ

Bronx, New York, United States

North Shore Univ Hosp

πŸ‡ΊπŸ‡Έ

Great Neck, New York, United States

Bellevue Hosp / New York Univ Med Ctr

πŸ‡ΊπŸ‡Έ

New York, New York, United States

Schneider Children's Hosp

πŸ‡ΊπŸ‡Έ

New Hyde Park, New York, United States

Cornell Univ Med College

πŸ‡ΊπŸ‡Έ

New York, New York, United States

Columbia Presbyterian Med Ctr

πŸ‡ΊπŸ‡Έ

New York, New York, United States

Metropolitan Hosp Ctr

πŸ‡ΊπŸ‡Έ

New York, New York, United States

Incarnation Children's Ctr / Columbia Presbyterian Med Ctr

πŸ‡ΊπŸ‡Έ

New York, New York, United States

Univ of Rochester Med Ctr

πŸ‡ΊπŸ‡Έ

Rochester, New York, United States

Harlem Hosp Ctr

πŸ‡ΊπŸ‡Έ

New York, New York, United States

Children's Hosp of the King's Daughters

πŸ‡ΊπŸ‡Έ

Norfolk, Virginia, United States

UMDNJ - Robert Wood Johnson Med School / Pediatrics

πŸ‡ΊπŸ‡Έ

New Brunswick, New Jersey, United States

SUNY - Brooklyn

πŸ‡ΊπŸ‡Έ

Brooklyn, New York, United States

Β© Copyright 2025. All Rights Reserved by MedPath